UK Markets close in 6 hrs 3 mins
  • FTSE 100

    6,983.50
    +43.92 (+0.63%)
     
  • FTSE 250

    22,472.04
    +116.59 (+0.52%)
     
  • AIM

    1,248.13
    +4.22 (+0.34%)
     
  • GBP/EUR

    1.1515
    +0.0004 (+0.04%)
     
  • GBP/USD

    1.3784
    -0.0001 (-0.0041%)
     
  • BTC-GBP

    44,438.58
    -1,397.62 (-3.05%)
     
  • CMC Crypto 200

    1,397.85
    +16.90 (+1.22%)
     
  • S&P 500

    4,170.42
    +45.76 (+1.11%)
     
  • DOW

    34,035.99
    +305.10 (+0.90%)
     
  • CRUDE OIL

    63.37
    -0.09 (-0.14%)
     
  • GOLD FUTURES

    1,764.90
    -1.90 (-0.11%)
     
  • NIKKEI 225

    29,642.69
    +21.70 (+0.07%)
     
  • HANG SENG

    28,793.14
    -107.69 (-0.37%)
     
  • DAX

    15,255.33
    +46.18 (+0.30%)
     
  • CAC 40

    6,234.14
    +25.56 (+0.41%)
     

Healthcare platform Agilon targets valuation of up to $9 billion in U.S. IPO

·1-min read

(Reuters) - Agilon Health is aiming for a valuation of up to $9 billion in its initial public offering (IPO), the healthcare platform said on Wednesday, joining a clutch of companies looking to cash in on the record run in U.S. capital markets.

The company said it planned to raise more than $1 billion in its IPO by selling 46.6 million shares at a price range of $20 and $23 per share.

Founded in 2016, Agilon health provides a care platform for primary care physicians.

The company will list on the New York Stock Exchange under the symbol "AGL," it said in a filing.

JP Morgan, Goldman Sachs and BofA are among the underwriters for the offering.

(Reporting by Niket Nishant and Mrinalika Roy in Bengaluru; Editing by Aditya Soni)